Cargando…

TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma

Trop-2, a cell surface glycoprotein, contains both extracellular epidermal growth factor-like and thyroglobulin type-1 repeat domains. Low TROP2 expression was observed in lung adenocarcinoma tissues as compared with their normal counterparts. The lack of expression could be due to either the loss o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jau-Chen, Wu, Yi-Ying, Wu, Jing-Yi, Lin, Tzu-Chieh, Wu, Chen-Tu, Chang, Yih-Leong, Jou, Yuh-Shan, Hong, Tse-Ming, Yang, Pan-Chyr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443948/ https://www.ncbi.nlm.nih.gov/pubmed/22419550 http://dx.doi.org/10.1002/emmm.201200222

Ejemplares similares

The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma
por: Hung, Pei-Fang, et al.
Publicado: (2013)

Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC
por: Che, Ting-Fang, et al.
Publicado: (2015)

MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma
por: Wang, Lu-Kai, et al.
Publicado: (2015)

Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
por: Hu, Yaozhong, et al.
Publicado: (2022)

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
por: Zhao, Ming, et al.
Publicado: (2023)

Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment
por: Sun, Xia, et al.
Publicado: (2021)

High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers
por: Chang, Yih-Leong, et al.
Publicado: (2017)

Phosphorylation of LCRMP-1 by GSK3β Promotes Filopoda Formation, Migration and Invasion Abilities in Lung Cancer Cells
por: Wang, Wen-Lung, et al.
Publicado: (2012)

The Antitumor Agent PBT-1 Directly Targets HSP90 and hnRNP A2/B1 and Inhibits Lung Adenocarcinoma Growth and Metastasis
por: Chen, Chi-Yuan, et al.
Publicado: (2014)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer
por: Hsu, Xiu-Rui, et al.
Publicado: (2023)

Integrative analyses of noncoding RNAs reveal the potential mechanisms augmenting tumor malignancy in lung adenocarcinoma
por: Shih, Jou-Ho, et al.
Publicado: (2020)

The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition
por: Wu, Shang-Gin, et al.
Publicado: (2016)

Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
por: Wu, Shang-Gin, et al.
Publicado: (2017)

TROP2 modulates the progression in papillary thyroid carcinoma
por: Sun, Huali, et al.
Publicado: (2021)

Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells
por: Nakato, Gaku, et al.
Publicado: (2020)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms
por: Liu, Haiyan, et al.
Publicado: (2017)

PSPC1 Potentiates IGF1R Expression to Augment Cell Adhesion and Motility
por: Jen, Hsin-Wei, et al.
Publicado: (2020)

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
por: Wu, Shang-Gin, et al.
Publicado: (2016)

Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells
por: Wu, Bin, et al.
Publicado: (2017)

Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma
por: Chang, Jan-Gowth, et al.
Publicado: (2016)

A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
por: Wu, Yi-Ying, et al.
Publicado: (2022)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
por: Raji, Rhoda, et al.
Publicado: (2011)

Biosafety and Proteome Profiles of Different Heat Inactivation Methods for Mycobacterium tuberculosis
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma
por: Hsiao, Yi-Jing, et al.
Publicado: (2016)

Corrigendum: Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
por: Lin, Ching-Wen, et al.
Publicado: (2017)

A literature review of the promising future of TROP2: a potential drug therapy target
por: Wen, Ying, et al.
Publicado: (2022)

Trop-2 protein as a therapeutic target: A focused review on Trop-2-based antibody-drug conjugates and their predictive biomarkers
por: Vranic, Semir, et al.
Publicado: (2022)

Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference
por: Kuo, Ting-Chun, et al.
Publicado: (2020)

Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region
por: Chen, Tseng-Cheng, et al.
Publicado: (2020)

Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan
por: Sheen, Yi-Shuan, et al.
Publicado: (2017)

Topically Applied Cross-Linked Hyaluronan Attenuates the Formation of Spinal Epidural Fibrosis in a Swine Model of Laminectomy
por: Lin, Cheng-Li, et al.
Publicado: (2019)

Trop-2 Is a Determinant of Breast Cancer Survival
por: Ambrogi, Federico, et al.
Publicado: (2014)

Targeting Trop-2 in solid tumors: future prospects
por: Zaman, Saif, et al.
Publicado: (2019)

Contrôles anti-dopage : trop, pas assez, autrement ?
por: Kintz, Pascal
Publicado: (2020)

Trop2: Jack of All Trades, Master of None
por: Lenárt, Sára, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1dm870erefg5js0prsck4ff4tm